Integrative Enzymatics
Santa Fe
About Integrative Enzymatics
Integrative Enzymatics is a biotechnology company dedicated to developing structure-based pharmaceutical products to treat chronic metabolic disorders. The company’s primary offering is an intellectual property portfolio that consists of two drugs used for the treatment of Type I Diabetes Mellitus and Type II Diabetes Mellitus. The efficacy of both pharmaceuticals have been demonstrated in silico, in vitro, and verified through pilot animal studies. Second round animal trials are ongoing. Integrative Enzymatics has developed a proprietary method of designing pharmaceuticals. Their flagship patented drug treats diabetes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Grant (Nov 2013)
- Website: integrativeenzymatics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/integrative-enzymatics-2907092 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.